.
MergerLinks Header Logo

Announced

Completed

Fidelity Management & Research led a $115m financial round in Kardium.

Financials

Edit Data
Transaction Value£84m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Acquisition

Completed

Private

medical solutions

Cross Border

Single Bidder

Medical Equipment

Canada

Minority

Friendly

Private Equity

Synopsis

Edit

Fidelity Management & Research, an American multinational financial services corporation, led a $115m financial round in Kardium, a provider of medical devices, with participation from T. Rowe Price Group, an American publicly owned global investment management firm. “We are tremendously excited to have Fidelity Management & Research Company join Kardium as a major investor, along with the T. Rowe Price funds. Their enthusiasm and support reflect the incredible success we have achieved with the Globe System and the potential we have to dramatically improve the treatment of atrial fibrillation for millions of patients worldwide. This financial backing now allows us to accelerate commercial sales in Europe and begin the FDA study for the Globe System,” Kevin Chaplin, Kardium CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US